Resistance to isoniazid in Mycobacterium tuberculosis can be mediated
by substitution of alanine for serine 94 in the InhA protein, the drug
's primary target. InhA was shown to catalyze the beta-nicotinamide ad
enine dinucleotide (NADH)-specific reduction of 2-trans-enoyl-acyl car
rier protein, an essential step in fatty acid elongation. Kinetic anal
yses suggested that isoniazid resistance is due to a decreased affinit
y of the mutant protein for NADH. The three-dimensional structures of
wild-type and mutant InhA, refined to 2.2 and 2.7 angstroms, respectiv
ely, revealed that drug resistance is directly related to a perturbati
on in the hydrogen-bonding network that stabilizes NADH binding.